Companies ›Healthcare ›HANNM.BK

HANNM.BK — SET (Bangkok) Healthcare Facilities & Services

Mukdahan International Hospital PCL

—

Open in Charts → Attach watcher ⌖

— —

USD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

0,00 %

Op margin

3,4 %

ROE

—

Net margin

1,7 %

Debt / equity

—

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

Mukdahan International Hospital PCL operates in the healthcare facilities and services industry, providing medical services and hospital care in Thailand.

Business. Mukdahan International Hospital PCL (HANNM.BK) is a healthcare facilities and services company headquartered in Thailand. The firm operates within the Healthcare Services & Equipment sector, providing medical services on a service-revenue basis. It is primarily listed on the Stock Exchange of Thailand (SET). Specific operating segments and geographic revenue breakdowns are not disclosed in the available data.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryHealthcare Facilities & Services

ActivityBiotechnology

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability

—

not yet wired

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning HANNM.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to HANNM.BK. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

Mukdahan International Hospital PCL (HANNM.BK) is a healthcare facilities and services company headquartered in Thailand. The firm operates within the Healthcare Services & Equipment sector, providing medical services on a service-revenue basis. It is primarily listed on the Stock Exchange of Thailand (SET). Specific operating segments and geographic revenue breakdowns are not disclosed in the available data.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryHealthcare Facilities & Services

ActivityBiotechnology

AI synthesis

GENERATED

Mukdahan International Hospital PCL has a capital structure with 560 million basic and diluted shares outstanding, indicating no dilution from stock options or convertible instruments. The company reported free cash flow of 7.3 million THB in the latest period, but liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.

The company's profitability is modest, with a net income of 1.98 million THB and an operating income of 3.93 million THB. Gross profit of 31.63 million THB suggests a relatively low-margin business model, which is typical for healthcare facilities. However, without industry-specific metrics or cohort medians, a direct comparison to industry benchmarks is not possible.

Geographic and segment exposure is not disclosed in the available data, but the company operates as a single entity in Thailand. Revenue concentration in a single geographic market may expose the company to local economic and regulatory risks.

Growth trajectory is not clearly defined in the available data, as no forward-looking revenue guidance or historical growth rates are provided. The company reported revenue of 115.99 million THB in the latest period, but without prior-year data, it is not possible to assess year-over-year growth.

Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the absence of going-concern language in source documents. Dilution risk is currently low, as basic and diluted shares are equal, and no adjustments were applied to the valuation.

Recent events or filings are not disclosed in the available data, and no transcripts or earnings call summaries are provided to assess management commentary or strategic direction.

Key takeaways

The company has no dilution risk as basic and diluted shares are equal.
Free cash flow is positive but relatively small at 7.3 million THB.
Profitability is low, with a net income of 1.98 million THB and a low-margin business model.
Liquidity risk could not be assessed due to missing balance-sheet data.
Revenue concentration in a single geographic market may increase exposure to local economic and regulatory risks.
No forward-looking guidance or historical growth data is available to assess growth trajectory.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Valuation FY

Market price

—

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

—

Net cashⓘ

—

Current ratioⓘ

—

Debt / equityⓘ

—

ROAⓘ

—

ROEⓘ

—

Cash conversionⓘ

726.0%

CapEx / revenueⓘ

-3.9%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskUnknown

Benchmarks vs cohort

Op Margin3,4 %Below median

Net Margin1,7 %Below median

Capex / Rev-3,9 %Above median

Cash Conv7,26Best in class

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Cash Conversion Ratio
operating_cash_flow / net_income
Capex To Revenue
capital_expenditure / revenue

Source documents

Mukdahan International Hospital PCL Market data — financials · 2026-05-28

Ownership & reference

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

HANNM.BKCanonical

SET (Bangkok) · USD

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskUnknown

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

— missing data

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation FY

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread